The Brain Can Convert One Opioid Peptide Into Another — Switching Receptor Targets
Brain tissue converts dynorphin (a kappa opioid) into leu-enkephalin (a delta opioid) via a metalloendopeptidase, effectively switching opioid signaling from one receptor type to another.
Quick Facts
What This Study Found
Dynorphin A(1-8) is extensively converted to leu-enkephalin by metalloendopeptidase EC 3.4.24.15 across all brain regions, effectively switching opioid signaling from kappa to delta receptors.
Key Numbers
How They Did This
Radiolabeled dynorphin A(1-8) was incubated with rat brain tissue. Products were identified by HPLC. Enzyme characteristics were determined using specific inhibitors and substrates of varying length.
Why This Research Matters
This shows the brain can actively convert one opioid signal into another. A kappa-receptor signal (dynorphin) becomes a delta-receptor signal (enkephalin), switching the type of opioid effect.
The Bigger Picture
This revealed that the brain's opioid system is more dynamic than a simple lock-and-key model. The brain doesn't just release fixed signals — it can transform them mid-transit, switching the type of opioid effect. This adds a layer of complexity to opioid pharmacology and could explain unexpected effects of opioid drugs.
What This Study Doesn't Tell Us
In-vitro tissue study. The enzyme's actual contribution in living brain tissue, where many enzymes compete, is unknown. High doses of peptidase inhibitors were needed.
Questions This Raises
- ?Is this conversion pathway altered in chronic pain or opioid tolerance?
- ?Could targeting this converting enzyme shift opioid signaling to favor specific therapeutic effects?
Trust & Context
- Key Stat:
- 60% conversion rate With competing enzymes blocked, 60% of dynorphin A(1-8) was converted to leu-enkephalin — switching from kappa to delta opioid signaling
- Evidence Grade:
- Preliminary in-vitro study using radiolabeled peptides. Demonstrates an enzymatic pathway but its quantitative importance in living brain requires validation.
- Study Age:
- Published in 1990. The concept of opioid peptide interconversion has been further developed and is now recognized as an important aspect of opioid signaling regulation.
- Original Title:
- Formation of [Leu5]enkephalin from dynorphin A(1-8) by rat central nervous tissue in vitro.
- Published In:
- Journal of neurochemistry, 54(4), 1379-85 (1990)
- Authors:
- Dixon, D M, Traynor, J R
- Database ID:
- RPEP-00153
Evidence Hierarchy
Frequently Asked Questions
What difference does it make whether dynorphin or enkephalin is active?
Dynorphin activates kappa opioid receptors, which can cause sedation and dysphoria. Enkephalin activates delta receptors, which are more involved in mood elevation and pain modulation. Converting one to the other fundamentally changes the biological effect.
Why is this conversion important?
It means the brain has a built-in mechanism to fine-tune its opioid signaling. Rather than relying solely on which peptide is released, the brain can actively transform opioid signals to adjust the balance of effects.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00153APA
Dixon, D M; Traynor, J R. (1990). Formation of [Leu5]enkephalin from dynorphin A(1-8) by rat central nervous tissue in vitro.. Journal of neurochemistry, 54(4), 1379-85.
MLA
Dixon, D M, et al. "Formation of [Leu5]enkephalin from dynorphin A(1-8) by rat central nervous tissue in vitro.." Journal of neurochemistry, 1990.
RethinkPeptides
RethinkPeptides Research Database. "Formation of [Leu5]enkephalin from dynorphin A(1-8) by rat c..." RPEP-00153. Retrieved from https://rethinkpeptides.com/research/dixon-1990-formation-of-leu5enkephalin-from
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.